Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'

How about this...

Company X spends billions researching a cure for a disease and ultimately fails to find a cure. Just business as usual. So sad, too bad.

Company Y spends billions researching a cure for a disease, and it successfully passes trials. At that point, they could apply for a government bailout, and if the costs are within reason, I think the state should pay for a good portion of the research and give the company a limited 5-10 year patent (depending on how many people are afflicted, expected revenues, etc) to recoup their costs and make a tidy profit. In exchange, they sign over all rights to such cure to the public domain. Winner winner, chicken dinner.

/r/technology Thread Parent Link -